Aridis Provides Corporate Update
LOS GATOS, Calif., June 24, 2024 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (OTC: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on recent developments.
Related news for (ARDS)
- Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024
- Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024
- Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
- Reviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV